COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 503: Articles 5021-5030  | Next

Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma markets in the eastern Democratic Republic of Congo
Mitangala, P. N., Irenge, L. M. W. B., Musubao, E. T., Kahindo, J. B. M., Ayonga, P. N., Safari, I. K., Kubuya, J. B., Ntabe, E. N., Kabangwa, R. K. S., Mutombo, G. N., Ambroise, J., GALA, J.-L.
10.1101/2023.02.17.23286083 — Posted: 2023-02-18
Rapidly Adaptable Multiplexed Yeast Surface Display Serological Assay for Immune Escape Screening of SARS-CoV-2 Variants
Lopez-Morales, J., Vanella, R., Utzinger, T., Schittny, V., Hirsiger, J., Osthoff, M., Berger, C. T., Guri, Y., Nash, M. A.
10.1101/2023.02.17.23286074 — Posted: 2023-02-18
Saline gargle-based SARS-CoV-2 genome surveillance for remote and rural setup with projections for post-pandemic monitoring
Khairnar, K., Tomar, S. S.
10.1101/2023.02.16.23286031 — Posted: 2023-02-18
Anti-inflammatory SARS-CoV-2 T cell immunity in asymptomatic seronegative Kenyan adults
Samandari, T., Ongalo, J., McCarthy, K. D., Biegon, R. K., Madiega, P., Mithika, A., Orinda, J., Mboya, G. M., Mwaura, P., Anzala, O., Onyango, C., Oluoch, F. O., Osoro, E., Dutertre, C.-A., Tan, N., Hang, S. K., Hariharaputran, S., Lye, D. C. B., Herman-Roloff, A., Le Bert, N., Bertoletti, A.
10.1101/2023.02.17.23286075 — Posted: 2023-02-18
CD4+ and CD8+ T cell and antibody correlates of protection against Delta vaccine breakthrough infection: A nested case-control study within the PITCH study
Neale, I., Ali, M., Kronsteiner, B., Longet, S., Abraham, P., Deeks, A. S., Brown, A., Moore, S. C., Stafford, L., Dobson, S. L., Plowright, M., Newman, T. A. H., Wu, M. Y., Crick COVID Immunity Pipeline, , Carr, E. J., Beale, R., Otter, A. D., Hopkins, S., Hall, V., Tomic, A., Payne, R. P., Barnes, E., Richter, A., Duncan, C. J. A., Turtle, L., de Silva, T. I., Carroll, M., Lambe, T., Klenerman, P., Dunachie, S., PITCH Consortium
10.1101/2023.02.16.23285748 — Posted: 2023-02-17
Lives and Livelihood, Not Quite a Trade-Off: A Cross-Country Analysis of the Short-Term Impact of COVID-19 Mortality on Real GDP
Suah, J. L.
10.1101/2023.02.13.23285835 — Posted: 2023-02-17
Vaccine waning and immune escape drive the second surge of Omicron spread in Hong Kong: A modeling study
ZOU, Y., Lo, W.-C., Ming, W.-k., Yuan, H.-Y.
10.1101/2023.02.14.23285831 — Posted: 2023-02-17
Evaluation of SARS-CoV-2 isolation in cell culture from nasal/nasopharyngeal swabs or saliva specimens of patients with COVID-19
Yazawa, S., Yamazaki, E., Saga, Y., Itamochi, M., Inasaki, N., Shimada, T., Oishi, K., Tani, H.
10.1101/2023.02.16.528881 — Posted: 2023-02-17
A burns and COVID-19 shared stress responding gene network deciphers CD1C-CD141- DCs as the key cellular components in septic prognosis
Liang, Q., Wang, L., Xu, J., Lin, A., Wu, Y., Tao, Q., Zhang, B., Min, H., Song, S., Gao, Q.
10.1101/2023.02.17.528914 — Posted: 2023-02-17
Effectiveness of SARS-CoV-2 Vaccines against Omicron Infection and Severe Events: A Systematic Review and Meta-Analysis of Test-Negative Design Studies
Song, S., Madewell, Z. J., Liu, M., Longini, I. M., Yang, Y.
10.1101/2023.02.16.23286041 — Posted: 2023-02-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).